Select Page

For more than 20 years, the Clinique médicale l’Actuel, under the direction of Dr. Réjean Thomas, has been bringing together healthcare professionals, with a focus in virology, to learn from guest experts and discuss the most relevant clinical practice challenges facing them today.

Antiretroviral Strategies and the Eradication of HIV

with Professor Katlama and Dr. Réjean Thomas

 

PROGRAM EXCERPT

HIGHLIGHTS

  • Recent cases of HIV eradication (Europe and US)
  • HIV DNA reservoir: the beginning of our understanding
  • Individualized ART based on the amount of HIV DNA in the reservoir

This activity is supported by
an educational grant from:

Bristol-Myers Squibb

SUMMARY

PARTICIPANTS

During this presentation, Professor Katlama talks about the two recent cases of HIV eradication in Europe and the US and discusses why they might have happened.

She also talks about the HIV DNA reservoir and the possible individualized ARTs based on the amount of DNA in the reservoir.

Réjean Thomas, MD, DHC

Réjean Thomas, MD, DHC

Interviewer

CEO | Founder
Clinique médicale l’Actuel:
Centre of Excellence HIV – STI – Hepatitis
Affiliated with the Centre hospitalier de l’Université de Montréal (CHUM)
Québec, Canada

Christine Katlama, MD

Christine Katlama, MD

Interviewee

Professor
Infectious Diseases
Head of the AIDS Clinical Research Unit
Hôpital de la Pitié-Salpêtrière
Paris, France

COMPLETE PROGRAM

Only Logged in users can see the full program
DISCLOSURE

ViroChannel has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.


Réjean Thomas, MD has a financial interest/relationship or affiliation in the form of: Advisory: AbbVie, Bristol-Myers Squibb Janssen, Gilead, Merck, ViiV Healthcare.

Christine Katlama, MD currently has no financial interests/relationships or affiliations in relation to this activity.


Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses. No responsibility is taken for errors or omissions. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

[comment]